UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR
15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 18, 2006
OMNICELL, INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
000-33043 |
|
94- 3166458 |
(State or other jurisdiction of
|
|
(Commission File Number) |
|
(IRS Employer
|
1201 Charleston Road
Mountain View, CA 94043
(Address of principal executive offices, including zip code)
(650) 251-6100
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01. Entry into a Material Definitive Agreement.
Omnicell, Inc. (the Company) has entered into an offer letter with Rob Seim, the Companys new Executive Vice President of Finance, setting forth Mr. Seims compensation and certain severance benefits.
Mr. Seim will be compensated at an initial salary of $220,000 per annum, and will receive an option to purchase 190,000 shares of the Companys Common Stock at an exercise price equal to the fair market value of the Companys Common Stock on the date of grant, which option shall vest over a 48-month period from the start of his employment. Mr. Seim also will be eligible for cash bonuses in an amount equal to between 35% and 45% of his annual salary based on the achievement of Company and personal performance objectives, subject to changes at the discretion of the Company. In addition, Mr. Seim will be entitled to severance pay equal to six months base salary if he is terminated without cause, and shall be entitled to severance pay equal to twelve months base salary and full vesting of his stock options if terminated without cause or constructively terminated following a change of control of the Company.
A copy of the offer letter between the Company and Mr. Seim is attached hereto as Exhibit 10.1.
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
1. Replacement of Principal Officer
On January 23, 2006, the Company announced that James T. Judson will step down as interim Chief Financial Officer of the Company effective following the filing of the Companys Annual Report on Form 10-K, expected to occur in March 2006. Following the filing of the Form 10-K, Mr. Judson will become the Companys Vice President of Corporate Development.
On January 23, 2006, Rob Seim joined the Company as Executive Vice President of Finance. Mr. Seim will become the Companys Chief Financial Officer following the filing of the Companys Annual Report on Form 10-K, expected to occur in March 2006.
Mr. Seim, age 46, began his business career in 1982 with IBM, serving in a variety of financial positions at three divisions over the course of fourteen years with IBM. From 1996 through 1999, he held a number of senior financial management positions at Bay Networks, which was acquired by Northern Telecom in September 1998. In the past six years, Mr. Seim has served as Chief Financial Officer of three early-stage technology companies, including Villa Montage Systems, Inc., a provider of residential broadband access management systems, Candera, Inc., a maker of network-based storage controllers, and most recently, Mirra, Inc., a vendor of personal backup servers. Mr. Seim holds a B.S. degree in accounting from California State University, Sacramento.
2
2. Replacement of Director
On January 18, 2006, John D. Stobo, Jr. announced his intention to resign from the Board of Directors of the Company, effective April 1, 2006. Mr. Stobo will be resigning in order to focus on his responsibilities as a partner of ABS Capital.
On January 18, 2006, the Board of Directors of the Company took action to appoint James T. Judson to the Board of Directors of the Company effective April 1, 2006, to fill the vacancy that will be created by the resignation of Mr. Stobo. Mr. Judson has served as the full-time interim Chief Financial Officer of the Company since April 2005. It is not currently anticipated that Mr. Judson will join any committees of the Board at the time of his appointment.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
|
|
Description |
10.1 |
|
Rob Seim Offer Letter |
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
Omnicell, Inc. |
||
|
|
||
|
|
||
Dated: January 24, 2006 |
By: |
/s/ Dan S. Johnston |
|
|
|
Dan S. Johnston, |
|
|
|
Senior Vice President |
|
|
|
and General Counsel |
4
Exhibit 10.1
|
Rob Seim |
Dear Rob:
Welcome to Omnicell! We are pleased to offer you the Executive Vice President and Chief Financial Officer position reporting to Randy Lipps. Your monthly salary will be $18,333.34, less payroll deductions and all required withholdings, which is an annual equivalent of $220,000.00. Omnicell will recommend, for approval by, our Board of Directors, an award to you of options to purchase up to 190,000 shares of Omnicell Common Stock at a price equal to the fair market value of such shares on the date of grant. Upon approval, those shares will become exercisable over a 48 month period. The options will be subject to the terms and conditions of Omnicells stock option plan and your grant agreement.
As Chief Financial Officer, you are also covered by the attached Change of Control document.
If your employment is terminated without cause you will receive severance pay equivalent to six (6)months salary at your base rate of pay in effect immediately prior to termination; provided you agree to execute Omnicells standard waiver and release agreement. Cause is defined as (1) conviction of any felony; (2) participation in fraud, misappropriation, embezzlement or other similar act of dishonesty or material misconduct against the Company (or its subsidiaries or affiliates); or (3) participation in any act materially contrary to the Companys best interests.
In addition, you will be eligible to participate in the Omnicell Quarterly Executive Bonus Plan wherein you may receive a bonus in the amount of up to 35% 45% of your base salary pending Board approval and paid out [quarterly] pursuant to the Omnicell Quarterly Executive Bonus Plan; provided, among other things, the companys and your personal objectives are met. Please note that participation in the Executive Bonus Plan is at the discretion of Omnicells management and that they reserve the right to make changes to such bonus plan at any time.
Your start date of employment will be mutually determined upon acceptance of this offer.
Employment at Omnicell is at-will employment, which means it may be terminated by you or by Omnicell at any time without liability, and is acknowledged by you upon signing this offer letter. In addition, Omnicell may change your position, duties, compensation, benefits and work location from time to time at its discretion. This offer is contingent upon successful completion of background and reference checks.
We have competitive medical, dental and vision plans as well as term life, long and short term disability insurance policies, 401(k) plan, and an Employee Stock Purchase Plan (ESPP). Details about these benefits are provided in the Employee Handbook and Summary Plan Descriptions, available for your review. Omnicell may, however, change compensation and benefits from time to time at its discretion
As a condition of employment and required by law, you must show proof of citizenship, permanent residency in the United States or authorization to work in the United States. To complete the federally-required verification form (I-9), we ask that you submit copies of this documentation with your new hire materials during your first week of employment. Documents may include a US Passport, birth certificate, Social Security Card, drivers license or Alien Registration Receipt Card.
As an Omnicell employee, you will be expected to abide by company policies and procedures, and acknowledge in writing that you have read and will comply with the companys Employee Handbook. As a condition of employment, you must read, sign and comply with the attached Proprietary Information Agreement which prohibits unauthorized use or disclosure of Company proprietary information. In addition as part of your duties for Omnicell, you may be assigned to work onsite with an Omnicell customer. Some of these customers have additional requirements that they impose upon individuals who work onsite at their business, including the requirement that you submit to drug-testing in certain instances. If you are assigned to work with such a customer, you will be given notice of the customers additional requirements and will be asked to consent to these requirements as a condition of your employment with Omnicell.
If you have any questions, please give me a call at (650) 251-6216. Please note the above offer is good for five (5) days from the date of issue.
On behalf of Randy Lipps, I am pleased to confirm your offer to join Omnicell. We are looking forward to having you on our team!
Again, we welcome you to Omnicell as we begin this exciting stage of our companys development and look forward to working with you. We believe you will make a significant contribution to the company and the opportunities available to you will be wide open as Omnicell grows to its potential.
Sincerely,
Grace Griffin
Vice President, Human Resources
To indicate your acceptance of the companys offer, please sign and date this letter in the space provided below and return it to Human Resources via confidential fax at (650) 251-6277 along with your completed and signed W-4 form. A duplicate is enclosed for your records. This letter, along with the Proprietary Information Agreement, Policy Against Trading on the Basis of Inside Information and the Code of Ethics between you and the Omnicell, set forth the terms of your employment with Omnicell and supersede any prior representations or agreements, whether written or oral. This letter may not be modified or amended except by a written agreement, signed by Omnicell and by you. The above offer is good for five (5) days from the date of issue.
|
|
|
|
Candidate Signature |
Date |
||
|
|
||
|
|
|
|
|
Anticipated Start Date |
To Rob Seim
Upon your acceptance of employment as Chief Financial Officer with Omnicell, Inc. (the Company), and subject to Board of Director approval, you shall also be granted the following benefit: in the event of an Acquisition of the Company (as defined below), and provided one of the following events occurs: (i) you are terminated without Cause (as defined below); (ii) the principal place of the performance of your responsibilities and duties is changed to a location outside of the San Mateo, Santa Clara, or San Francisco counties; or (iii) there is a material reduction in your responsibilities and duties without Cause; then (a) you shall receive severance pay equivalent to twelve (12)months salary at your base rate of pay in effect immediately prior to the occurrence of the triggering events described above (and further provided that you agree to execute Omnicells standard waiver and release agreement); and (b) the unvested portion of each of your stock options granted to you under the Companys 1999 Equity Incentive Plan, the 2003 Equity Incentive Plan, the 2004 Equity Incentive Plan, (collectively, the Plans) shall accelerate and immediately become fully-vested and exercisable.
An Acquisition, as used herein shall mean any consolidation or merger of the Company with or into any other corporation or other entity or person in which the stockholders of the Company prior to such consolidation, merger or reorganization shall own less than fifty percent (50%) of the voting stock of the continuing or surviving entity of such consolidation, merger or reorganization, any other corporate reorganization in which in excess of fifty percent (50%) of the Companys voting power is transferred , or any transaction in which any person, together with its affiliates, accumulates fifty percent or more of the Companys voting power.
As used herein, Cause shall mean: (i) conviction of any felony; (ii) participation in fraud, misappropriation, embezzlement or other similar act of dishonesty or material misconduct against the Company or any subsidiaries or affiliates thereof; or (iii) participation in any act materially contrary to the Companys best interest.
Acceleration may be limited in certain circumstances, in particular, if any such acceleration the (Benefit) would (i) constitute a parachute payment within the meaning of Section 280G of the Internal Revenue Code and (ii) but for this amendment, be subject to the excise tax imposed by Section 4999 of the Internal Revenue Code, then such Benefit will be reduced to the extent necessary so that no portion of the Benefit would be subject to the excise tax, as determined in good faith by the Company; provided, however, that if, in the absence of any such reduction (or after such reduction), you believe that the Benefit or any portion thereof (as reduced, if applicable) would be subject to the excise tax, the Benefit shall be reduced (or further reduced) to the extent determined by you in your discretion so that the excise tax would not apply. If, not withstanding any such reduction (or in the absence of such reduction), the Internal Revenue Service determines that you are liable for the excise tax as a result of the Benefit, then you will be obligated to return to the Company, within thirty (30) days of such determination by the IRS, a portion of the Benefit sufficient such that none of the benefit retained by you constitutes a parachute payment within the meaning of Code Section 280G that is subject to the excise tax.
The Company is please to provide this benefit to you in recognition of your continuing dedication to the success of the Company. Should you have any questions regarding this matter, please contact the undersigned at 650-251-6120.
Omnicell, Inc.
Randall A. Lipps
Chairman, President and CEO